Form 4 holding
Chief Corp Dev.&Strat. Officer
EyePoint Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 30,570
- Estimated value
- $623,628
- Report date
- 06 Jan 2024
- Price
- $20.40
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount